Abbott Says It Settled Sandoz Patent Suit Over Biaxin

Abbott Laboratories said it settled a patent-infringement suit against Novartis AG’s Sandoz over a generic version of the antibiotic Biaxin XL.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.